Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

NCT06825845 is registered in ClinicalTrials.gov with CARsgen Therapeutics Co., Ltd. as lead sponsor.

NCT NCT06825845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06825845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy
Lead sponsor
CARsgen Therapeutics Co., Ltd.
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
June 30, 2040
Enrollment
1,500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed or refractory multiple myeloma